Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Lenalidomide
Related studies linked through entity extraction aliases.
Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE1
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
- Status
- COMPLETED
- Phase
- PHASE2
Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry
- Status
- COMPLETED
- Phase
- N/A
Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2